TDGF1 Kit CLIA

N° du produit ABIN5659119

Ce kit ELISA Chemiluminescent est destiné à la mesure quantitative de Humain TDGF1.

Aperçu rapide pour TDGF1 Kit CLIA (ABIN5659119)

Antigène: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Reactivité: Humain

Méthode de détection: Chemiluminescent

Type de méthode: Sandwich ELISA

Gamme de detection: 13.7 pg/mL - 10000 pg/mL

Application: ELISA

Type d'échantillon: Tissue Homogenate

Détail du produit TDGF1 Kit CLIA

Seuil minimal de détection: 13.7 pg/mL

Fonction: Human Teratocarcinoma Derived Growth Factor 1 (TDGF1) CLIA Kit for detecting TDGF1 in tissue homogenates

Analytical Method: Quantitative

Specificité: This assay has high sensitivity and excellent specificity for detection of Teratocarcinoma Derived Growth Factor 1 (TDGF1). No significant cross-reactivity or interference between Teratocarcinoma Derived Growth Factor 1 (TDGF1) and analogues was observed.

Sensibilité: 5.3 pg/mL

Ingrédients:

• Pre-coated, ready to use 96-well strip plate
• Standar
• Detection Reagent A
• Detection Reagent B
• Substrate A
• Substrate B
• Assay Diluent A
• Assay Diluent B
• Wash Buffer (30x concentrate)
• Standard Diluent
• Plate Sealer
• Instruction Manual

Matériel non inclus:

• Microplate Reader with 450 nm filter
• Single or multi-channel pipettes with high precision and disposable tips
• Microcentrifuge tubes
• Deionized or distilled watter
• Absorbent paper for blotting the microplate
• Container for wash solution
• 0.01 M (or 1x) Phosphate Buffered Saline (PBS), ph 7.0-7.2

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Commentaires:

This product is tested and assembled before shipping to ensure that it meets its quality specifications. All kits are tested to confirm that they fall within their defined Inter- and Intra- assay coefficient of variation.

Volume d'échantillon: 100 μL

Durée du test: 3 h

Plaque: Pre-coated

Protocole: The microplate provided in this kit has been pre-coated with an antibody specific to Teratocarcinoma Derived Growth Factor 1 (TDGF1). Standards or samples are then added to the appropriate microplate wells with a biotin-conjugated antibody specific to Teratocarcinoma Derived Growth Factor 1 (TDGF1). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. Then the mixture of substrate A and B is added to generate glow light emission kinetics. Upon plate development, the intensity of the emitted light is proportional to the Teratocarcinoma Derived Growth Factor 1 (TDGF1) level in the sample or standard.,

Précision du teste: Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Teratocarcinoma Derived Growth Factor 1 (TDGF1) were tested 20 times on one plate, respectively
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Teratocarcinoma Derived Growth Factor 1 (TDGF1) were tested on 3 different plates, 8 replicates in each plate. CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Restrictions: For Research Use only

Stockage

Conseil sur la manipulation: Do not allow to contact skin or eyes. Calibrators, controls and specimen samples should be assayed in duplicate. Once the procedure has been started, all steps should be completed without interruption.

Stock: 4 °C,-20 °C

Stockage commentaire: -20°C. Bring all reagents to room temperature before beginning test. The kit may be stored at 4°C for immediate use within two days upon arrival. Reseal any unused strips with desiccant pack. Minimize freeze/thaw cycles.

Date de péremption: 12 months

Détail du antigène

Antigène: TDGF1 (Teratocarcinoma-Derived Growth Factor 1 (TDGF1))

Autre désignation: Teratocarcinoma Derived Growth Factor 1

Sujet: Gene Aliases: CR, CRGF, CRIPTO, Cripto-1, Epidermal growth factor-like cripto protein CR1, Cripto-1 growth factor

ID gène: 6997

UniProt: P13385

Pathways: EGFR Signaling Pathway